These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease? Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic inhibitors of tumor necrosis factor in Crohn's disease. Ganesan S; Travis SP; Ahmad T; Jazrawi R Curr Opin Investig Drugs; 2002 Sep; 3(9):1301-6. PubMed ID: 12498004 [TBL] [Abstract][Full Text] [Related]
5. Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept). Yazisiz V; Avci AB; Erbasan F; Yildirim B; Terzioğlu E Colorectal Dis; 2008 Nov; 10(9):953-4. PubMed ID: 18294265 [TBL] [Abstract][Full Text] [Related]
6. Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab. Korzenik JR Gastroenterol Clin North Am; 2004 Jun; 33(2):285-301, ix. PubMed ID: 15177539 [TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE). Bondeson J; Maini RN Int J Clin Pract; 2001 Apr; 55(3):211-6. PubMed ID: 11351775 [TBL] [Abstract][Full Text] [Related]
8. Infliximab induced T lymphocyte apoptosis in Crohn's disease. van den Brande J; Hommes DW; Peppelenbosch MP J Rheumatol Suppl; 2005 Mar; 74():26-30. PubMed ID: 15742461 [TBL] [Abstract][Full Text] [Related]
9. TNF-alpha neutralization in cytokine-driven diseases: a mathematical model to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome. Jit M; Henderson B; Stevens M; Seymour RM Rheumatology (Oxford); 2005 Mar; 44(3):323-31. PubMed ID: 15585509 [TBL] [Abstract][Full Text] [Related]
10. Anti-TNFalpha therapy for rheumatoid arthritis: an update. Taylor PC Intern Med; 2003 Jan; 42(1):15-20. PubMed ID: 12583612 [TBL] [Abstract][Full Text] [Related]
11. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results. Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981 [TBL] [Abstract][Full Text] [Related]
13. Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis. Stokes DG; Kremer JM Semin Arthritis Rheum; 2003 Aug; 33(1):1-18. PubMed ID: 12920692 [TBL] [Abstract][Full Text] [Related]
14. Immunological therapies for rheumatoid arthritis. Edwards CJ Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791 [TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of etanercept (TNFR:Fc) and its use in a patient with Crohn's disease. Srivastava MD Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):125-41. PubMed ID: 11458980 [TBL] [Abstract][Full Text] [Related]
16. Afelimomab. Vincent JL Int J Clin Pract; 2000 Apr; 54(3):190-3. PubMed ID: 10829362 [TBL] [Abstract][Full Text] [Related]
17. Diverse effects of infliximab and etanercept on T lymphocytes. Sieper J; Van Den Brande J Semin Arthritis Rheum; 2005 Apr; 34(5 Suppl1):23-7. PubMed ID: 15852251 [TBL] [Abstract][Full Text] [Related]
18. Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials. Rahimi R; Nikfar S; Abdollahi M Biomed Pharmacother; 2007 Jan; 61(1):75-80. PubMed ID: 17184965 [TBL] [Abstract][Full Text] [Related]
19. [Anti-TNF alfa therapy in ankylosing spondylitis]. Cravo AR; Tavares V; Da Silva JC Acta Med Port; 2006; 19(2):141-50. PubMed ID: 17187716 [TBL] [Abstract][Full Text] [Related]
20. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Wolfe F; Michaud K Am J Med; 2004 Mar; 116(5):305-11. PubMed ID: 14984815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]